{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:50:51Z","timestamp":1782316251665,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1011176"],"award-info":[{"award-number":["NRF-2021R1A2C1011176"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bioadv.2023.213606","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T02:08:41Z","timestamp":1693274921000},"page":"213606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages"],"prefix":"10.1016","volume":"154","author":[{"given":"Nhan Phan","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Yeol","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warisraporn","family":"Tangchang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","article-title":"Targeted drug delivery to tumors: myths, reality and possibility","volume":"153","author":"Bae","year":"2011","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2014","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.bioadv.2023.213606_bb0015","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"16","key":"10.1016\/j.bioadv.2023.213606_bb0020","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213606_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/nnm.14.13","article-title":"Macrophages associated with tumors as potential targets and therapeutic intermediates","volume":"9","author":"Vinogradov","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213606_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213606_bb0035","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s40005-022-00584-w","article-title":"Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research","volume":"52","author":"Zeb","year":"2022","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/cb900266r","article-title":"Advances in the biology and chemistry of sialic acids","volume":"5","author":"Chen","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioadv.2023.213606_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.dci.2018.05.008","article-title":"Siglecs: a journey through the evolution of sialic acid-binding immunoglobulin-type lectins","volume":"86","author":"Bornh\u00f6fft","year":"2018","journal-title":"Developmental & Comparative Immunology"},{"issue":"11","key":"10.1016\/j.bioadv.2023.213606_bb0050","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/biology10111178","article-title":"Siglecs as therapeutic targets in cancer","volume":"10","author":"Lim","year":"2021","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jfma.2019.10.019","article-title":"Functions and therapeutic targets of Siglec-mediated infections, inflammations and cancers","volume":"120","author":"Lin","year":"2021","journal-title":"J. Formos. Med. Assoc."},{"issue":"11","key":"10.1016\/j.bioadv.2023.213606_bb0060","article-title":"Sialoglycans on lymphatic endothelial cells augment interactions with Siglec-1 (CD169) of lymph node macrophages","volume":"35","author":"D\u2019Addio","year":"2021","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s15010-021-01606-9","article-title":"CD169\/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity","volume":"49","author":"Doehn","year":"2021","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-89786-0","article-title":"SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients","volume":"11","author":"Ostendorf","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies","volume":"23","author":"De Palma","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.bioadv.2023.213606_bb0080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd.2016.111","article-title":"Immuno-oncologists eye up macrophage targets","volume":"15","author":"Morrison","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol."},{"issue":"21","key":"10.1016\/j.bioadv.2023.213606_bb0090","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1111\/febs.15647","article-title":"Tools to study and target the Siglec\u2013sialic acid axis in cancer","volume":"288","author":"L\u00e4ubli","year":"2021","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.bioadv.2023.213606_bb0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s13346-021-00973-y","article-title":"Are third-generation active-targeting nanoformulations definitely the best? In vitro and in vivo comparisons of pixantrone-loaded liposomes modified with different sialic acid derivatives","volume":"12","author":"Song","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0105","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s13346-018-0496-6","article-title":"Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency","volume":"8","author":"Zhang","year":"2018","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.bioadv.2023.213606_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101959","article-title":"Docetaxel: an update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer","volume":"60","author":"Imran","year":"2020","journal-title":"Journal of Drug Delivery Science and Technology"},{"issue":"16","key":"10.1016\/j.bioadv.2023.213606_bb0115","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.3390\/cancers13164233","article-title":"Tumor microenvironment in breast Cancer\u2014updates on therapeutic implications and pathologic assessment","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1166\/jcsb.2012.1020","article-title":"Preparation, characterization and applications of liposomes: state of the art","volume":"1","author":"Laouini","year":"2012","journal-title":"Journal of Colloid Science and Biotechnology"},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0125","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajps.2014.03.001","article-title":"Application of sialic acid\/polysialic acid in the drug delivery systems","volume":"9","author":"Zhang","year":"2014","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/08982100903347923","article-title":"Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation","volume":"20","author":"Jaafar-Maalej","year":"2010","journal-title":"Journal of Liposome Research"},{"key":"10.1016\/j.bioadv.2023.213606_bb0140","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jconrel.2018.08.011","article-title":"Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity","volume":"286","author":"Gu","year":"2018","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.bioadv.2023.213606_bb0145","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1016\/j.biomaterials.2012.01.036","article-title":"Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots","volume":"33","author":"Muthu","year":"2012","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijpharm.2011.09.045","article-title":"Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells","volume":"421","author":"Muthu","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.bioadv.2023.213606_bb0155","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/jps.24019","article-title":"Preparation, characterization, and pharmacodynamics of thermosensitive liposomes containing docetaxel","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2023.213606_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120552","article-title":"Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity","volume":"602","author":"Sui","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2023.213606_bb0165","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2021.06.027","article-title":"Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy","volume":"337","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2023.213606_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.01.005","article-title":"Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy","volume":"558","author":"Zheng","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"16","key":"10.1016\/j.bioadv.2023.213606_bb0180","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioadv.2023.213606_bb0185","doi-asserted-by":"crossref","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2023.213606_bb0190","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"10","key":"10.1016\/j.bioadv.2023.213606_bb0195","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/nn800669n","article-title":"Shedding light on tumors using nanoparticles","volume":"2","author":"Rao","year":"2008","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0200","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2016.06.057","article-title":"Docetaxel-loaded liposomes: the effect of lipid composition and purification on drug encapsulation and in vitro toxicity","volume":"514","author":"Pereira","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"19","key":"10.1016\/j.bioadv.2023.213606_bb0205","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.biomaterials.2014.03.022","article-title":"The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid\u2013octadecylamine conjugate","volume":"35","author":"She","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2017.03.034","article-title":"Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity","volume":"523","author":"Zhou","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2478\/s11658-013-0108-x","article-title":"Membrane potential-dependent binding of polysialic acid to lipid monolayers and bilayers","volume":"18","author":"Nowotarski","year":"2013","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"12","key":"10.1016\/j.bioadv.2023.213606_bb0220","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.1507706113","article-title":"Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells","volume":"113","author":"Perdicchio","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-020-00604-7","article-title":"Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells","volume":"18","author":"da Rocha","year":"2020","journal-title":"Journal of Nanobiotechnology"},{"issue":"6","key":"10.1016\/j.bioadv.2023.213606_bb0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11095-017-2135-1","article-title":"Formulation of a sustained release docetaxel loaded cockle shell-derived calcium carbonate nanoparticles against breast cancer","volume":"34","author":"Hammadi","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioadv.2023.213606_bb0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.colsurfb.2018.11.077","article-title":"Rational design of polymer-lipid nanoparticles for docetaxel delivery","volume":"175","author":"Albano","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2023.213606_bb0240","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijbiomac.2014.06.029","article-title":"Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies","volume":"69","author":"Jain","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"25","key":"10.1016\/j.bioadv.2023.213606_bb0245","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.biomaterials.2013.04.052","article-title":"Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/pharmaceutics10030139","article-title":"Lyophilization of liposomal formulations: still necessary, still challenging","volume":"10","author":"Franz\u00e9","year":"2018","journal-title":"Pharmaceutics"},{"issue":"28","key":"10.1016\/j.bioadv.2023.213606_bb0255","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.biomaterials.2012.05.026","article-title":"Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0260","first-page":"111","article-title":"Factors affecting drug release from liposomes","volume":"13","author":"Lindner","year":"2010","journal-title":"Current Opinion in Drug Discovery & Development"},{"issue":"03","key":"10.1016\/j.bioadv.2023.213606_bb0265","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1055\/s-0042-1757511","article-title":"Novel docetaxel-loaded micelles based on all-trans-retinoic acid: preparation and pharmacokinetic study in rats","volume":"4","author":"Yang","year":"2022","journal-title":"Pharmaceutical Fronts"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2023.213606_bb0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2018.05.032","article-title":"Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer","volume":"546","author":"Zhang","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.bioadv.2023.213606_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.bioadv.2023.213606_bb0280","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bbamem.2016.09.005","article-title":"The effect of polyethylene glycol-modified lipids on the interaction of HIV-1 derived peptide\u2013dendrimer complexes with lipid membranes","volume":"1858","author":"Melikishvili","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Biomembranes"},{"issue":"12","key":"10.1016\/j.bioadv.2023.213606_bb0285","first-page":"3395","article-title":"PLGA nanoparticles surface decorated with the sialic acid","volume":"31","author":"Bondioli","year":"2010","journal-title":"N-acetylneuraminic acid, Biomaterials"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0290","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.colsurfb.2010.11.023","article-title":"Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles","volume":"83","author":"Zheng","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"9","key":"10.1016\/j.bioadv.2023.213606_bb0295","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.polymdegradstab.2006.03.004","article-title":"Preparation of poly (lactide-co-glycolide-co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution","volume":"91","author":"Zhang","year":"2006","journal-title":"Polym. Degrad. Stab."},{"key":"10.1016\/j.bioadv.2023.213606_bb0300","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.chemphyslip.2016.10.005","article-title":"In vitro release kinetics model fitting of liposomes: an insight","volume":"201","author":"Jain","year":"2016","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bioadv.2023.213606_bb0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2014.06.041","article-title":"Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems","volume":"190","author":"Peppas","year":"2014","journal-title":"J. Control. Release"},{"issue":"2\u2013S","key":"10.1016\/j.bioadv.2023.213606_bb0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.22270\/jddt.v12i2-S.5402","article-title":"Comparison of the use of kinetic model plots and DD solver software to evaluate the drug release from Griseofulvin tablets","volume":"12","author":"Ekenna","year":"2022","journal-title":"Journal of Drug Delivery and Therapeutics"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2023.213606_bb0315","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","article-title":"On the use of the Weibull function for the discernment of drug release mechanisms","volume":"309","author":"Papadopoulou","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213606_bb0320","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.xphs.2020.05.006","article-title":"Novel thermosensitive polymer-modified liposomes as nano-carrier of hydrophobic antitumor drugs","volume":"109","author":"Xi","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbadis.2015.10.017","article-title":"Acidosis differently modulates the inflammatory program in monocytes and macrophages","volume":"1862","author":"Riemann","year":"2016","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"23","key":"10.1016\/j.bioadv.2023.213606_bb0330","doi-asserted-by":"crossref","first-page":"12370","DOI":"10.1074\/jbc.M116.721258","article-title":"Induction of Siglec-1 by endotoxin tolerance suppresses the innate immune response by promoting TGF-\u03b21 production","volume":"291","author":"Wu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioadv.2023.213606_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118706","article-title":"Terminating the renewal of tumor-associated macrophages: a sialic acid-based targeted delivery strategy for cancer immunotherapy","volume":"571","author":"Ding","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0340","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00280-011-1746-1","article-title":"In vitro evaluation of clinical activity and toxicity of anticancer drugs using tumor cells from patients and cells representing normal tissues","volume":"69","author":"Haglund","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.bioadv.2023.213606_bb0345","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1742-7843.2011.00844.x","article-title":"Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells","volume":"110","author":"Deepa","year":"2012","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.bioadv.2023.213606_bb0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bej.2019.05.007","article-title":"A dual fluorescent 3-D multicellular coculture of breast cancer MCF-7 and fibroblast NIH-3T3 cells for high throughput cancer drug screening","volume":"148","author":"Xin","year":"2019","journal-title":"Biochem. Eng. J."},{"issue":"24","key":"10.1016\/j.bioadv.2023.213606_bb0355","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/molecules27248838","article-title":"Docetaxel loaded in copaiba oil-nanostructured lipid carriers as a promising DDS for breast cancer treatment","volume":"27","author":"Carvalho","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0360","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/s41598-020-62501-1","article-title":"Optimization of docetaxel loading conditions in liposomes: proposing potential products for metastatic breast carcinoma chemotherapy","volume":"10","author":"Vakili-Ghartavol","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0365","first-page":"349","article-title":"In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes","volume":"2","author":"He","year":"2010","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"issue":"1\u20132","key":"10.1016\/j.bioadv.2023.213606_bb0370","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2017.10.058","article-title":"Fluorescence-labeled liposome accumulation in injured colon of a mouse model of T-cell transfer-mediated inflammatory bowel disease","volume":"494","author":"Yamasaki","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bioadv.2023.213606_bb0375","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bioadv.2023.213606_bb0380","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/j.1349-7006.2012.02411.x","article-title":"Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.bioadv.2023.213606_bb0385","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/mrm.26854","article-title":"Visualization of macrophage recruitment in head and neck carcinoma model using fluorine-19 magnetic resonance imaging","volume":"79","author":"Khurana","year":"2018","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bioadv.2023.213606_bb0390","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221076194","article-title":"Molecular imaging of tumor-associated macrophages in cancer immunotherapy","volume":"14","author":"Li","year":"2022","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"3","key":"10.1016\/j.bioadv.2023.213606_bb0395","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/pharmaceutics14030545","article-title":"The fate of sialic acid and PEG modified Epirubicin liposomes in aged versus young cells and tumor mice models","volume":"14","author":"Sui","year":"2022","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.bioadv.2023.213606_bb0400","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2217\/nnm.11.79","article-title":"In vivo biodistribution of nanoparticles","volume":"6","author":"Almeida","year":"2011","journal-title":"Nanomedicine"},{"issue":"8","key":"10.1016\/j.bioadv.2023.213606_bb0405","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C9BM01732A","article-title":"Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy","volume":"8","author":"Li","year":"2020","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-019-0529-4","article-title":"A chitosan-based cascade-responsive drug delivery system for triple-negative breast cancer therapy","volume":"17","author":"Niu","year":"2019","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bioadv.2023.213606_bb0415","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2012.07.010","article-title":"Analysis on the current status of targeted drug delivery to tumors","volume":"164","author":"Kwon","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0420","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1038\/s41598-020-68631-w","article-title":"Histological validation of in vivo assessment of cancer tissue inhomogeneity and automated morphological segmentation enabled by optical coherence Elastography","volume":"10","author":"Plekhanov","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioadv.2023.213606_bb0425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cells9010046","article-title":"Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses","volume":"9","author":"Anfray","year":"2019","journal-title":"Cells"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823003291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950823003291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:53:50Z","timestamp":1757426030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950823003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":85,"alternative-id":["S2772950823003291"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213606","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialic acid-decorated liposomes enhance the anti-cancer efficacy of docetaxel in tumor-associated macrophages","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2023.213606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"213606"}}